Results 121 to 130 of about 48,221 (285)

Dupilumab Treatment Improves Sense of Smell in Patients With Chronic Rhinosinusitis With Nasal Polyps – Pooled Results From the SINUS-24 and SINUS-52 Phase 3 Trials [PDF]

, 2020
Joaquim Mullol, Joseph K. Han, John V. Bosso, Leda Mannent, Nikhil Amin, Seong Cho, Claus Bachert   +6 more
openalex   +1 more source

Endotyping of nasal polyps in a multiracial Asian population [PDF]

, 2022
Shuhui Xu, M Vallei, Tze Choong Charn, Hwang Jacqueline, Neville Wei Yang Teo   +4 more
openalex   +1 more source

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract—the B Cell Side

Allergy, EarlyView.
ABSTRACT Allergic diseases are on the rise worldwide, driven by respiratory epithelial barrier dysfunction that promotes sensitization to inhalant allergens such as pollen, dust mites, pet dander, and fungal spores. These antigens trigger IgE‐mediated immune responses that lead to diseases such as allergic rhinitis (AR) and asthma.
Ola Grimsholm, Mohammed Zghaebi, Bita Hambrecht, Tanja Kalic, Christopher C. Udoye, Rudolf Manz, Barbara Bohle, Katarzyna M. Sitnik, Julia Eckl‐Dorna, Heimo Breiteneder   +9 more
wiley   +1 more source

Effect of anti-leukotrienes versus corticosteroids in prevention of recurrence of nasal polyps [PDF]

Ali Abdallah Abdelrahman, Ahmed Mohamed El-Sheikh, Hamada Saber Salama   +2 more
openalex   +1 more source

Elevated expression of IL-17RB and ST2 on myeloid dendritic cells is associated with a Th2-skewed eosinophilic inflammation in nasal polyps [PDF]

, 2018
Rui Zheng, Dan Wang, Kai Wang, Wenxiang Gao, Qintai Yang, Lijie Jiang, Min Zhou, Yujie Cao, Jianbo Shi, Yueqi Sun   +9 more
openalex   +1 more source

Type 2 and Type 17 Invariant Natural Killer T Cells Contribute to Local Eosinophilic and Neutrophilic Inflammation and Their Function Is Regulated by Mucosal Microenvironment in Nasal Polyps

, 2022
Xiaoyan Ye, Qing Bao, Hexin Chen, Qingxiang Meng, Qianying Li, Lin Sun, Jian Li, Wenbin Lei, Weiping Wen, Wenjing He, Linyi Jiao, Bixing Fang, Yifang Gao, Chunwei Li   +13 more
openalex   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source

Dupilumab Dampens Mucosal Type 2 Response During Acetylsalicylic Acid Challenge in N‐ERD Patients

Clinical &Experimental Allergy, EarlyView.
Dupilumab therapy reduced elevated type 2 cytokine responses post‐ASA provocation in N‐ERD patients, independent of ASA tolerance, and revealed novel mechanistic insights by modulating acute type 2 immunity. Transcriptomic analysis showed concurrent downregulation of lipid and peroxisome pathways during ASA challenge in N‐ERD patients after 24 weeks of
Julia Eckl‐Dorna, Christina Morgenstern, Katharina Poglitsch, Tamara Arnoldner, Katharina Gangl, Tina J. Bartosik, Nicholas J. Campion, Aldine Tu, Victoria Stanek, Sven Schneider, Christine Bangert   +10 more
wiley   +1 more source

Correlation between the Prostaglandin D2/E2 Ratio in Nasal Polyps and the Recalcitrant Pathophysiology of Chronic Rhinosinusitis Associated with Bronchial Asthma

, 2008
Tsuyoshi Yoshimura, Mamoru Yoshikawa, Nobuyoshi Otori, Shinichi Haruna, Hiroshi Moriyama   +4 more
openalex   +1 more source

Angiectatic nasal polyp diagnostic quandary of sinonasal malignancy

, 2020
Nur Afeena A. F. A. Kashaf, Andrew H. K. Chin, Zambri M. Ibrahim, Irnawati W. A. Rahman, Shakir K. A. Rahman   +4 more
openalex   +2 more sources